These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 203971)

  • 1. The effects of ACTH4-10 versus placebo in the memory of symptomatic geriatric volunteers.
    Will JC; Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1978 Jan; 14(1):25-7. PubMed ID: 203971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phosphatidylserine and memory disorders in the aged].
    Nerozzi D; Aceti F; Melia E; Magnani A; Marino R; Genovesi G; Amalfitano M; Cozza G; Murgiano S; De Giorgis G
    Clin Ter; 1987 Mar; 120(5):399-404. PubMed ID: 3034480
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of single dose ACTH 4-10 versus placebo on the memory of symptomatic geriatric volunteers.
    Abuzzahab FS; Will JC; Zimmermann RL
    J Clin Psychopharmacol; 1982 Feb; 2(1):65-9. PubMed ID: 6279702
    [No Abstract]   [Full Text] [Related]  

  • 4. ACTH4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndrome.
    Branconnier RJ; Cole JO; Gardos G
    Psychopharmacol Bull; 1978 Jan; 14(1):27-30. PubMed ID: 203972
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of the efficacy of ACTH4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis.
    Butter HJ; Lapierre Y; Firestone P; Blank A
    J Clin Psychopharmacol; 1983 Aug; 3(4):226-30. PubMed ID: 6309918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical testing of drugs that act on learning and memory (proceedings)].
    Ressler P
    Pharmazie; 1979; 34(5-6):308-9. PubMed ID: 390555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss].
    Allain H; Belliard S; Lieury A; Menard G; Patat A; Le Coz F; Gandon JM
    Therapie; 1996; 51(2):155-62. PubMed ID: 8763050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function.
    Leckman J; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(4):301-3. PubMed ID: 4932747
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of ACTH 4-10 on ECT-induced memory dysfunctions.
    Small JG; Small IF; Milstein V; Dian DA
    Acta Psychiatr Scand; 1977 Apr; 55(4):241-50. PubMed ID: 193359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of optic neuritis.
    Schmidt D
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():493-500. PubMed ID: 6326916
    [No Abstract]   [Full Text] [Related]  

  • 12. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)].
    Schneider E; Jacobi P; van Riezen H; Voerman JW; Fischer PA
    Pharmacopsychiatria; 1981 Sep; 14(5):155-9. PubMed ID: 6270708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physostigmine treatment of progressive supranuclear palsy.
    Litvan I; Gomez C; Atack JR; Gillespie M; Kask AM; Mouradian MM; Chase TN
    Ann Neurol; 1989 Sep; 26(3):404-7. PubMed ID: 2802540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of age-associated memory impairment with guanfacine.
    McEntee WJ; Crook TH; Jenkyn LR; Petrie W; Larrabee GJ; Coffey DJ
    Psychopharmacol Bull; 1991; 27(1):41-6. PubMed ID: 1862205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testing of geriatric drugs by means of psychologic testing methods, based on the example of the Geriatric Pharmation].
    Simon WC
    Med Monatsschr; 1974 Jun; 28(6):262-4. PubMed ID: 4612319
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
    Maki PM; Gast MJ; Vieweg AJ; Burriss SW; Yaffe K
    Neurology; 2007 Sep; 69(13):1322-30. PubMed ID: 17893293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 20. [One-year therapy with dihydroergocristine for treatment of impaired alertness and memory in elderly patients. Placebo-controlled multicenter study].
    Agliati G; Lazzaroni M; Mariani G; Marras F; Massetto N; Menozzi C; Ortenzi E; Perna G; Puppo N; Santambrogio S
    Arzneimittelforschung; 1992 Nov; 42(11A):1414-6. PubMed ID: 1492865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.